Ningxi Yu is currently a Process Development Principal Scientist specializing in Attribute Science at Amgen. They possess extensive experience in therapeutic oligonucleotide sequencing and impurity analysis utilizing advanced techniques such as LC and high-resolution mass spectrometry. Previous roles include Research Scientist III at Nitto Denko Avecia Inc. and Senior Research Scientist at Nitto Avecia, along with an internship at Moderna Therapeutics. Ningxi earned a Ph.D. in Analytical Chemistry from the University of Cincinnati, a Master's in Computational Chemistry from Central China Normal University, and a Bachelor's in Polymer Materials and Engineering from Wuhan Institute of Technology.
This person is not in any teams
This person is not in any offices